Automatic exposure control

Canon Designs Recognized with Internationally Renowned iF Design Awards for the 30th Consecutive Year

Retrieved on: 
Wednesday, March 27, 2024
Printing, USM, CXDI, Acquisition, AEC, V1000, Automatic exposure control, CAD, Medical imaging

Melville, NY, March 27, 2024 (GLOBE NEWSWIRE) -- Canon U.S.A. Inc., a leader in digital imaging solutions, today announced that six Canon product designs were recognized by iF International Forum Design GmbH with prestigious 2024 iF Design Awards.

Key Points: 
  • Melville, NY, March 27, 2024 (GLOBE NEWSWIRE) -- Canon U.S.A. Inc., a leader in digital imaging solutions, today announced that six Canon product designs were recognized by iF International Forum Design GmbH with prestigious 2024 iF Design Awards.
  • Notably, this marks Canon's 30th consecutive year of being recognized for outstanding design prowess.
  • The accolades underscore Canon's unwavering commitment to producing products that seamlessly blend top-tier performance with cutting-edge design aesthetics.
  • Its ergonomic and lightweight design includes sculpted handgrips and rounded corners for improved productivity and ease of use.

Konica Minolta Announces Significant Expansion of Dynamic Digital Radiography Across Multiple Facility Types and Clinical Care Areas

Retrieved on: 
Monday, July 10, 2023
Amos, Barium, Partnership, DDR, Workflow, Patient satisfaction, Pelvis, Anatomy, Claustrophobia, Doctor of Philosophy, Stomach, Lung transplantation, MRI, Motion, Konica Minolta, Hospital, Patient, Digital radiography, Emory Healthcare, Hearing, Automatic exposure control, MSK, Fluoroscopy, Edmond, Injury, Health, Alta Bates Summit Medical Center, Medical imaging, Radiology

Unlike fluoroscopy, DDR is a series of individual digital X-ray images acquired at high speed and low doses, allowing the visualization of anatomy in motion.

Key Points: 
  • Unlike fluoroscopy, DDR is a series of individual digital X-ray images acquired at high speed and low doses, allowing the visualization of anatomy in motion.
  • DDR has broad utilization across multiple clinical care specialties, including pulmonary, musculoskeletal, lung transplantation, swallowing studies and more, and is being used for both contrast and non-contrast studies.
  • Greg Miner, Appleton Area Health Chief Executive Officer, says, “To bring this type of diagnostic care to Appleton is truly remarkable.
  • DDR is the type of technology you would expect to find in only large metropolitan areas in our region.

Konica Minolta Healthcare Continues to Transform X-ray, Introducing New Systems Featuring Dynamic Digital Radiography at RSNA 2022

Retrieved on: 
Thursday, November 3, 2022
Doctor of Philosophy, TFT, US FDA, Konica Minolta, Workflow, Radiological Society of North America, Time, RSNA, GLOBE, Minolta, DDR, ER, OR, Digital radiography, Efficiency, Electronics, Motion, Health, CCU, US, Respiration, Automatic exposure control, Innovation, ICU, Glass, Patient satisfaction, Technology, Solution, Medical imaging, Medicine, Facebook

In 2020, Konica Minolta Healthcare launched Dynamic Digital Radiography (DDR) , and now the company is extending this advancement to the new KDR Flex Overhead X-ray System.

Key Points: 
  • In 2020, Konica Minolta Healthcare launched Dynamic Digital Radiography (DDR) , and now the company is extending this advancement to the new KDR Flex Overhead X-ray System.
  • Konica Minolta is delivering more capabilities with digital radiography that advance and redefine imaging diagnostics and are available on multiple systems to best meet each customers most demanding needs, says Guillermo Sander , PhD, Marketing Director for Digital Radiography, Konica Minolta Healthcare.
  • About Konica Minolta Healthcare Americas, Inc.
    Konica Minolta Healthcare is a world-class provider and market leader in medical diagnostic imaging and healthcare information technology.
  • Konica Minolta Healthcare Americas, Inc., headquartered in Wayne, NJ, is a division of Konica Minolta, Inc.For more information on Konica Minolta Healthcare Americas, Inc., follow us on LinkedIn , Twitter and Facebook , or visit https://healthcare.konicaminolta.us .

Simplivia Healthcare Unveils Latest Innovation in its Closed System Drug-Transfer Device Portfolio at the 2022 EAHP Conference

Retrieved on: 
Wednesday, March 16, 2022
Solution, Administration, Conference, FDA, Pharmacy, Nursing, Risk, CSTD, Prince Sultan Advanced Technology Research Institute, Safety, Journal of Oncology Pharmacy Practice, Canadian Society of Hospital Pharmacists, CE, Expert, Automatic exposure control, Workflow, Pharmaceutical industry, Medical device

Simplivia will launch Chemfort for the first time at the 26th Anniversary European Association of Hospital Pharmacists (EAHP) Conference.

Key Points: 
  • Simplivia will launch Chemfort for the first time at the 26th Anniversary European Association of Hospital Pharmacists (EAHP) Conference.
  • Simplivia introduce for the first time the Chemfort Closed Administration portfolio, which is designed for use by nurses when administering hazardous drugs.
  • "We are excited to showcase the Chemfort Closed system transfer device portfolio, which has received CE and FDA ONB product code," said Simplivia CEO Oded Grinstein.
  • For Simplivia activities at the EAHP 2022 please click here: https://simplivia.activetrail.biz/meet-us-EAHP
    Visit the EAHP website to learn more about the conference.

Simplivia Healthcare Unveils Latest Innovation in its Closed System Drug-Transfer Device Portfolio at the 2022 EAHP Conference

Retrieved on: 
Wednesday, March 16, 2022
Transfer, Solution, Administration, Conference, FDA, Pharmacy, Nursing, Risk, CSTD, Prince Sultan Advanced Technology Research Institute, Safety, Journal of Oncology Pharmacy Practice, Canadian Society of Hospital Pharmacists, CE, Expert, Automatic exposure control, Workflow, Pharmaceutical industry, Medical device

KIRYAT SHMONA, Israel, March 16, 2022 /PRNewswire/ -- Simplivia Healthcare Ltd., a leading global medical device developer, has announced the upcoming launch of Chemfort™, its newest closed system transfer device (CSTD). Chemfort™ reduces the risk of exposure for healthcare professionals when preparing and administering hazardous drugs.

Key Points: 
  • The company will showcase its latest Closed System Drug-Transfer Device, Chemfort, at this year's EAHP 26thAnniversary Conference
    KIRYAT SHMONA, Israel, March 16, 2022 /PRNewswire/ --Simplivia Healthcare Ltd., a leading global medical device developer, has announced the upcoming launch of Chemfort, its newest closed system transfer device (CSTD).
  • Simplivia will launch Chemfort for the first time at the 26th Anniversary European Association of Hospital Pharmacists (EAHP) Conference.
  • "We are excited to showcase the Chemfort Closed system transfer device portfolio, which has received CE and FDA ONB product code," said Simplivia CEO Oded Grinstein.
  • For Simplivia activities at the EAHP 2022 please click here: https://simplivia.activetrail.biz/meet-us-EAHP
    Visit the EAHP website to learn more about the conference.